Self-Assembling Vaccine Platform Using Heat Shock Protein Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccine development strategies are time-consuming and labor-intensive, making them inadequate for rapid response to emerging threats and impractical for generating personalized vaccines, especially for fast-acting and highly contagious diseases.
Innovation Solution
Pharmaceutical compositions comprising heat shock proteins fused to biotin-binding proteins, which can form non-covalent complexes with biotinylated components, such as antigens or antibodies, to induce an immune response and stimulate cellular immunity, allowing for rapid production of vaccines and enhancing the potency of existing therapeutics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current vaccine development strategies are used to identify and characterize target antigens, then vaccines can be developed to eradicate infection or disease, but the process is time-consuming and labor-intensive
Solution Approach 1:
The invention segments the vaccine development process into two parts: (1) a universal heat shock protein platform that can be rapidly produced, and (2) variable antigen components that can be easily swapped. This segmentation allows the core delivery mechanism to be pre-developed and reused, dramatically reducing the time required to develop vaccines for new threats while maintaining reliability through the proven HSP platform
Solution Approach 2:
The invention performs preliminary action by pre-developing and characterizing the heat shock protein vaccine platform in advance. The HSP components can be produced and validated before any specific threat emerges, allowing rapid response to new diseases by simply adding the relevant antigen information without needing to re-develop the entire vaccine system
2Reliability
If current vaccine development strategies are used to characterize target antigens, then specific vaccines can be developed, but the process is impractical for generating personalized vaccines
Solution Approach 1:
The invention applies universality by creating a single heat shock protein platform that can serve multiple functions: it can deliver different antigens for different diseases, accommodate personalized cancer antigens, and work with various delivery methods. The universal HSP backbone combined with customizable antigen components enables both specific targeting and easy personalization without requiring separate development processes
Solution Approach 2:
The invention enables parameter changes by allowing easy modification of the antigen sequence or identity in the vaccine composition. The HSP platform maintains its core structure while the antigen portion can be rapidly changed to match different disease threats or individual patient needs, making personalized vaccine production practical through simple parameter adjustment rather than complete re-manufacturing
3Reliability
If current vaccine development strategies are used, then vaccines can be developed for known threats, but they are insufficient for fast-acting and highly contagious diseases
Solution Approach 1:
The invention performs preliminary action by pre-establishing the heat shock protein production and delivery system before any disease outbreak. The HSP platform is validated and ready for rapid deployment, allowing immediate response to fast-acting and highly contagious diseases by simply incorporating the relevant antigen information without needing to conduct lengthy development studies first
Solution Approach 2:
The invention segments vaccine development into a reusable HSP delivery platform and a rapidly interchangeable antigen component. This allows the proven HSP system to be immediately deployed for new threats while only the small antigen portion needs to be updated, dramatically increasing response speed to emerging diseases while maintaining the reliability of the tested delivery mechanism
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compositions enable the rapid generation of personalized vaccines and enhance the immune response, facilitating the production of potent vaccines and therapeutics that can target specific antigens without the need for extensive antigen characterization, thereby addressing the limitations of existing vaccine development strategies.
Implementation Method 1
non-covalently bound to at least one, two, three, or four biotinylated components
Data Source
AI summary
Provided herein are self-assembling pharmaceutical compositions comprising a heat shock protein fused to a biotin-binding protein, wherein the biotin-binding protein is non-covalently bound to four biotinylated components, and further wherein at least two of the four biotinylated components are not identical.